Huntingdon Life Sciences, Harlan Laboratories and three subsidiaries have announced that the combined companies have rebranded as Envigo.

“Today we are delighted to officially rebrand as Envigo,” said Brian Cass, chief executive officer, Envigo. “This marks a significant milestone for the five companies that came together to create Envigo and demonstrates the great progress we have made in our integration. Our customers are increasingly seeking partners who can deliver a variety of services in a coordinated manner, and the breadth of Envigo’s offering strengthens our ability to deliver on that need.”

Envigo employs 3,800 people and has sales approaching $500 million. The company is a top-three provider of non-clinical research services and research models and services to the pharmaceutical, chemical and crop protection industries, as well as academic institutions and government agencies worldwide.

“We have received very positive comments from customers to the on-going integration of our businesses and to our new name,” said Adrian Hardy, chief operating officer, Envigo. “Today we have become Envigo, and our goal is to establish the company as the number one partner for both customer service and scientific excellence.”